140 related articles for article (PubMed ID: 38293968)
21. Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositis.
Martis N; Viau P; Zenone T; Andry F; Grados A; Ebbo M; Castela E; Brihaye B; Denis E; Liguori S; Audemard A; Schoindre Y; Morin AS; Terrier B; Marcq L; Mounier N; Lidove O; Chaborel JP; Quinsat D
Eur Radiol; 2019 Dec; 29(12):6708-6716. PubMed ID: 31250167
[TBL] [Abstract][Full Text] [Related]
22. Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort.
Barsotti S; Dastmalchi M; Notarnicola A; Leclaire V; Dani L; Gheorghe K; Ekholm L; Bottai M; Tjärnlund A; Lundberg IE
Semin Arthritis Rheum; 2020 Jun; 50(3):492-497. PubMed ID: 32024593
[TBL] [Abstract][Full Text] [Related]
23. Assessing PET/CT's diagnostic accuracy in idiopathic myopathies.
Liang F; Li G; Guo J; Zhang W; Chang X
Hell J Nucl Med; 2024; 27(1):46-54. PubMed ID: 38678384
[TBL] [Abstract][Full Text] [Related]
24. Frequencies and clinical associations of myositis-related antibodies in The Netherlands: A one-year survey of all Dutch patients.
Platteel ACM; Wevers BA; Lim J; Bakker JA; Bontkes HJ; Curvers J; Damoiseaux J; Heron M; de Kort G; Limper M; van Lochem EG; Mulder AHL; Saris CGJ; van der Valk H; van der Kooi AJ; van Leeuwen EMM; Veltkamp M; Schreurs MWJ; Meek B; Hamann D
J Transl Autoimmun; 2019 Dec; 2():100013. PubMed ID: 32743501
[TBL] [Abstract][Full Text] [Related]
25. Sarcopenia and Myositis Revisited: Emerging Role of Fluorine-18 Fluorodeoxyglucose PET in Muscle Imaging.
Debs P; Al-Zaghal A; Solnes LB; Alavi A
PET Clin; 2023 Jan; 18(1):31-38. PubMed ID: 36442964
[TBL] [Abstract][Full Text] [Related]
26. Fluorine-18 labeled fluorodeoxyglucose positron emission tomography/computed tomography used in diagnosing connective tissue diseases in fever of unknown origin/inflammatory of unknown origin patients.
Chen Z; Li Y; Wang Q; Weng S; Zhou Y; Zhu J
Clin Rheumatol; 2022 Mar; 41(3):839-846. PubMed ID: 34674082
[TBL] [Abstract][Full Text] [Related]
27. Evaluating the diagnostic utility of new line immunoassays for myositis antibodies in clinical practice: a retrospective study.
Montagnese F; Babačić H; Eichhorn P; Schoser B
J Neurol; 2019 Jun; 266(6):1358-1366. PubMed ID: 30840145
[TBL] [Abstract][Full Text] [Related]
28. Fluorodeoxyglucose positron emission tomography-computed tomography findings in a first series of 10 patients with polyarteritis nodosa.
Fagart A; Machet T; Collet G; Quéméneur T; Ben Ticha R; Verstraete M; Le Gouellec N; Demailly F; Rousselin C
Rheumatology (Oxford); 2022 Apr; 61(4):1663-1668. PubMed ID: 34302460
[TBL] [Abstract][Full Text] [Related]
29. 18F-Fluorodeoxyglucose positron emission tomography for the assessment of myositis: a case series.
Pipitone N; Versari A; Zuccoli G; Levrini G; Macchioni P; Bajocchi G; Salvarani C
Clin Exp Rheumatol; 2012; 30(4):570-3. PubMed ID: 22703951
[TBL] [Abstract][Full Text] [Related]
30. Performance of myositis-specific antibodies detected on myositis line immunoassay to diagnose and sub-classify patients with suspected idiopathic inflammatory myopathy, a retrospective records-based review.
Beaton TJ; Gillis D; Prain K; Morwood K; Anderson J; Goddard J; Baird T
Int J Rheum Dis; 2021 Sep; 24(9):1167-1175. PubMed ID: 34250724
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Importance of Bone Marrow Uptake on Baseline
Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
[TBL] [Abstract][Full Text] [Related]
32. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.
Manwatkar A; Padiyar S; Nair A; Jha A; Kumar S; Yadav B; Prakash JAJ; Das JK; Mathew J
Clin Rheumatol; 2023 Dec; 42(12):3289-3297. PubMed ID: 37801141
[TBL] [Abstract][Full Text] [Related]
33. Validation of 2017 classification criteria for adult and juvenile idiopathic inflammatory myopathies proposed by EULAR/ACR in Chinese patients.
Zhang X; Yang X; Ji L; Zhang Z
Int J Rheum Dis; 2019 Jul; 22(7):1278-1282. PubMed ID: 31124267
[TBL] [Abstract][Full Text] [Related]
34. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
[TBL] [Abstract][Full Text] [Related]
35. Detection of inflammatory lesions by f-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis.
Owada T; Maezawa R; Kurasawa K; Okada H; Arai S; Fukuda T
J Rheumatol; 2012 Aug; 39(8):1659-65. PubMed ID: 22753657
[TBL] [Abstract][Full Text] [Related]
36. A diagnostic cohort study on the accuracy of 18-fluorodeoxyglucose (
Proli C; De Sousa P; Jordan S; Anikin V; Devaraj A; Love SM; Shackcloth M; Kostoulas N; Papagiannopoulos K; Haqzad Y; Loubani M; Sellitri F; Granato F; Bush A; Marchbank A; Iyer S; Scarci M; Lim E;
BMJ Open; 2018 Feb; 8(2):e019471. PubMed ID: 29437755
[TBL] [Abstract][Full Text] [Related]
37. The value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-up.
Yapar Z; Kibar M; Yapar AF; Paydas S; Reyhan M; Kara O; Buyukdereli G; Aydin M; Kelle AP; Unal I; Disel U; Yavuz S; Sahin B; Erkisi M
Nucl Med Commun; 2010 Jan; 31(1):59-66. PubMed ID: 19952921
[TBL] [Abstract][Full Text] [Related]
38. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
39. Muscle involvement on 18F-FDG PET-CT in polymyalgia rheumatica. A controlled retrospective study of 101 patients.
Wendling D; Sondag M; Giraud N; Chouk M; Boulahdour H; Prati C; Verhoeven F
Joint Bone Spine; 2020 May; 87(3):225-228. PubMed ID: 32007650
[TBL] [Abstract][Full Text] [Related]
40. Fluorodeoxyglucose positron emission tomography (18F-FDG PET)-computed tomography (CT) in the initial staging of bladder cancer: a single institution experience.
Shahait M; Abu-Hijlih R; Farkouh A; Obeidat S; Salah S; Abdlkadir AS; Al-Ibraheem A
J Egypt Natl Canc Inst; 2023 Jul; 35(1):21. PubMed ID: 37455263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
